Avacta Share Discussion Threads

[fuzzy777] 24/5/2024 14:18

Go away you tool

[pwhite73] 24/5/2024 14:14

JakNife - "Meanwhile Whitey took outrageous remuneration rewards for failure"I do not and have never worked for this company.

[1347] 24/5/2024 10:41

Avacta entered into the collaboration with Tufts on 24th July 2018 according to the RNS on that date. 6 years later they are still at Phase 1a. Arisaph had already been working on ARI-3996 and ARI-6000 since 2010, they ended the project in 2016.

[amanitaangelicus] 23/5/2024 17:09

I like big cohorts ...rns better than the silence. Where s Smith? Wish we knew the full story. The ii.s will know of course.

[john henry] 23/5/2024 13:38

That's another one of the hundreds of defamatory remarks you've made about the company. Let's ping the scam one over to Avacta

[john henry] 23/5/2024 13:35

Funds seeing an in flow of money for the first time in 3 years let's see what happens when risk comes back into the market

[pwhite73] 23/5/2024 12:49

For the record all the money PIs invested in this scam are in the hands of Avacta.

[john henry] 23/5/2024 12:12

For the record all your defamatory posts are in the hands of Avacta

[john henry] 23/5/2024 12:10

TBH Whitey I'm surprised you've never had a call from Lawyers. The number of times you've have publicly calked the BOD liars for all to see would imho warrant a court appearance.

[john henry] 23/5/2024 12:07

Kindly comment on one of the trial subjects where if these patients have only months to live as you claim which to be honest you know SFA about there condition.They are still receiving treatment after18 months TBH very disappointing reply and a clutching of straws comment.

[pwhite73] 23/5/2024 11:50

Cancers thrive in healthy bodies and if untreated they eventually kill the healthy host body. Once the host body is dead the cancer cells die as well for there is no live tissue to feed on and expand within.

The patients Avacta are using are terminally ill and not people that have ten years of life left but people with only months if less. So as their bodies weaken the cancers themselves can naturally shrink as they have less healthy tissue to expand within.

This is what an independent review can determine. Has the cancer shrunk in people that are dying because of a weakened body or because of the application of AVA6000.

This whole clinical trial if you can call it that is not kept totally in house for no reason.

[john henry] 23/5/2024 11:39

So how become a patient that been on the Ava6000 trial for 12 months and still on the trial has seen a dramatic shrinkage in his Tumours . Surely if no DOX was being delivered into the Tumour as you claim and that the company are blatantly lying about the data. The scans would have shown a growth in the tumours because as you claim no DOX is being delivered.

[pwhite73] 23/5/2024 11:33

john henry - "So the fact that they have seen no side effects and no Dox in the plasma when dosing 3.5 times the legal limit of Dox suggests to you that Precision doesn’t work."

Yes. They could be dosing 300 times the legal limit and there would be no side effects if the DOX was not been released at all. They've claimed they've recorded DOX in the tumours. This is a totally meaningless statement. How much and when did they record it. Was it the night before the terminally ill patient died?

Their unverified results are totally meaningless.

If they were able to deliver 3.5 times DOX to the tumour with no side effects. Eli Lilly, Pfizer, AstraZeneca et al would be bulldozing Avacta's door down to partner with them. Instead the CEO has resigned or been sacked with no reasons given.

[tomzimerman] 23/5/2024 11:28

Couldn't agree more, rampers paradise here lol

[john henry] 23/5/2024 11:26

So the fact that they have seen no side effects and no Dox in the plasma when dosing 3.5 times the legal limit of Dox suggests to you that Precision doesn't work.The problem is Whitey you've been on your negative campaign against the company for so many years you haven't got the balls to acknowledged your statement is false. The Precision platform DOES work the data proofs that undeniably.

[pwhite73] 23/5/2024 11:24

1347 - "I've told you once now that I have researched Avacta quite a bit "

You can't research anything outside of the RNS statements as there is no peer review for the AVA6000. We can only surmise what's going on.

1347 - "the fact is AVA6000 is nowhere near to being on the market"

That's not the reason why the price is tanking and they have had to rely on bucket shop finance. A drug can be at pre-clinical stage years away from commercialisation and the company can still be snapped for hundreds of millions by a major. What the majors look for its potential, a breakthrough at the earliest possible stage. AVA6000 has shown no such potential whatsoever.

john henry is right. You're talking AVA6000 down but you have no real understanding as to why its failing.

[1347] 23/5/2024 11:15

johnhenry No I am not missing any points, I've told you once now that I have researched Avacta quite a bit and understand the platforms, the fact is AVA6000 is nowhere near to being on the market and nor is anything else, and at the end of the day that's what counts.

pwhite - I'm not going to get into splitting hairs with you again on what you think something should be called, like the death spiral finance. You can call it what you want but a clinical trial is what it is.

[pwhite73] 23/5/2024 10:48

john henry - "Does the Platform work Answer YES"

The answer is NO. This is why they've gone for DOX and Velcade. These two cancer drugs are out of patent. Had AVCT gone for a drug that was still protected via its patent they would have had to collaborate with the patent owner, another drug firm and demonstrate to them how AVA6000 delivers their drug more safely and efficiently.

This is something the company could not have done because the preCISION platform does not work. This is also the reason why they have no partners and there has been no peer reviews.

Is it all beginning to make sense now?